Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
65.4%
% of BBH's 28 holdings also in IBBQ
8.5%
% of IBBQ's 200 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus IBBQ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in IBBQ |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 8.7% | 8.8% | 8.7% |
|
AMGEN INC | 15.4% | 7.9% | 7.9% |
|
VERTEX PHARMACEUTICALS INC | 9.8% | 7.9% | 7.9% |
|
GILEAD SCIENCES INC | 7.8% | 8.9% | 7.8% |
|
ALNYLAM PHARMACEUTICALS INC | 3.4% | 3.2% | 3.2% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to IBBQ
|
AMGEN INC | 7.5% |
|
IQVIA HOLDINGS INC | 5.4% |
 |
ICON PLC | 4.2% |
 |
ARGENX SE ADR | 4.0% |
|
BEIGENE LTD. SPONSORED ADR | 3.1% |
|
NATERA INC | 2.7% |
|
BIO-TECHNE CORPORATION | 2.3% |
|
ILLUMINA INC | 2.2% |
|
QIAGEN NV | 2.1% |
|
CHARLES RIVER LABORATORIES | 2.0% |
BBH Underweight Relative to IBBQ
 |
ASTRAZENECA PLC-SPONS ADR | -4.1% |
|
UNITED THERAPEUTICS CORP | -1.6% |
 |
SANOFI-AVENTIS-ADR | -1.5% |
|
VIATRIS, INC. | -1.4% |
|
ROYALTY PHARMA PLC CLASS A | -1.3% |
|
INSMED INC | -1.2% |
|
GILEAD SCIENCES INC | -1.1% |
|
MEDPACE HOLDINGS, INC. | -1.1% |
|
SUMMIT THERAPEUTICS INC | -0.9% |
|
ROIVANT SCIENCES LTD. | -0.9% |